To functionally validate whether CTLA-4negative anti-CD123 CAR T cells are responsible for sustained anti-leukemia effects and subsequently improved survival in AML-bearing mice, CTLA-4negative or CTLA-4positive CAR T cells were transferred into leukemia-bearing mice. The gene discussed is IL3RA; the disease is acute myeloid leukemia.